CBLB502: Clinical Trials

2 trials of CBLB502, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Withdrawn 1

Follow CBLB502: new trials by email Literature Review of CBLB502 trials Research Report on CBLB502

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy
entolimod, intensity-modulated radiation therapy, cisplatin - Mucositis, Recurrent Squamous Cell Carcinoma of the Hypopharynx
Phase 1WithdrawnRoswell Park Cancer Institute2014-01-012013-12-11
Entolimod in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By Surgery
entolimod, pharmacological study, laboratory biomarker analysis - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedRoswell Park Cancer Institute252012-01-012022-07-22

Conditions studied

Mucositis (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Tongue Neoplasms (1)

Sponsors

Roswell Park Cancer Institute (2)

Countries

United States (1)

Top investigators

Alex Adjei (1)  ·  Anurag Singh (1)